NCT05907343

Brief Summary

The goal of this clinical study is to investigate the effectiveness of non-invasive stimulation to enhance cognitive control abilities in older adults with and without cognitive impairment. The main questions it aims to answer are:

  • whether it is possible to restore various cognitive functions in older adults by delivering theta burst stimulation (TBS), a form of transcranial magnetic stimulation, and
  • whether closed-loop TBS is able to induce therapeutic benefits that outperform open-loop TBS. Participants play a cognitive video game while a brain-computer interface (BCI) analyzes their electroencephalogram (EEG) signals and decodes the presence or absence of the contingent negative variation (CNV) potential, a marker of cognitive control. The BCI triggers TBS when its outputs indicate that the participant is not engaged properly in the video game. Researchers will compare the effects of closed-loop and open-loop TBS using the outcome metrics described below to see how much cognitive restorations is achievable with each stimulation modality.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
13mo left

Started May 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
May 2023Oct 2027

Study Start

First participant enrolled

May 31, 2023

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

June 7, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 18, 2023

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2027

Last Updated

September 2, 2026

Status Verified

August 1, 2026

Enrollment Period

4.4 years

First QC Date

June 7, 2023

Last Update Submit

August 28, 2026

Conditions

Keywords

MCIOlder adultsCognitive controlMemory impairmentMemory enhancement

Outcome Measures

Primary Outcomes (1)

  • Cognitive Assessment Batteries

    NIH Toolbox - Cognition Battery: A computerized battery assessing multiple cognitive domains. The primary metric for all subtests is the age- and education-adjusted T-score (normative mean = 50, standard deviation = 10). Includes: Dimensional Change Card Sort, Face-Name Associative Memory Test, Flanker Inhibitory Control and Attention Test, Picture Sequence Memory Test, Rey Auditory Verbal Learning Test, Pattern Comparison Processing Speed Test

    Up to 8 weeks after intervention

Secondary Outcomes (6)

  • Accuracy of the BCI classifier output

    Up to 8 weeks after intervention

  • Behavioral performance of the video game task

    Up to 8 weeks after intervention

  • N-Back Task

    Up to 8 weeks after intervention.

  • Affective Flexibility Task

    Up to 8 weeks after intervention

  • Perseverative Thinking Questionnaire

    Up to 8 weeks after intervention

  • +1 more secondary outcomes

Study Arms (2)

Closed-Loop TBS

ACTIVE COMPARATOR
Device: Closed-loop TBS

Open-Loop TBS

ACTIVE COMPARATOR
Device: Open-loop TBS

Interventions

A BCI records and analyzes the participant's EEG as they perform cognitively demanding video game tasks. The BCI delivers TBS with a real coil when its output indicates that the participant is not properly engaged in the video game.

Closed-Loop TBS

A BCI records and analyzes the participant's EEG as they perform cognitively demanding video game tasks. TBS with the real coil is delivered irrelevant of the BCI decoder output.

Open-Loop TBS

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Older adults
  • Ages between 60 to 90 years
  • Good general health
  • Normal or corrected vision
  • Completed elementary school education or able to understand middle school level experiment instructions
  • Self reports cognitive complaints
  • Cognitively normal young adults
  • Ages between 18 to 35 years
  • Good general health
  • Normal or corrected vision
  • Completed elementary school education or able to understand middle school level experiment instructions

You may not qualify if:

  • Self-report of neurological or psychiatric diseases that could be contraindicated for TMS (e.g., personal history of epilepsy/seizure brain damage, history of fainting, bipolar disorder, schizophrenia, current substance use disorder, etc.).
  • Medications that elevate seizure threshold (e.g., stimulant medication, high dose bupropion).
  • Factors hindering EEG acquisition and rTMS delivery (e.g., skin infection, wounds, dermatitis, unable to access the scalp of the participant (e.g., unremovable wig).
  • Current participation in amyloid infusion treatment for Alzheimer's disease.
  • Do not have the capacity to provide informed consent and does not have a Legally Authorized Representative.
  • Resting motor threshold below the power limit in the laboratory. (Will be check on the first visit)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Health Discovery Building

Austin, Texas, 78712, United States

RECRUITING

MeSH Terms

Conditions

Cognitive DysfunctionAlzheimer DiseaseMemory Disorders

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersDementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • José del R. Millán, PhD

    University of Texas at Austin

    PRINCIPAL INVESTIGATOR
  • Jared F. Benge, PhD, ABPP

    University of Texas at Austin

    PRINCIPAL INVESTIGATOR
  • Crystal M. Lantrip, PhD, LP

    Neuropsychological Assessment Clinic

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 7, 2023

First Posted

June 18, 2023

Study Start

May 31, 2023

Primary Completion (Estimated)

October 31, 2027

Study Completion (Estimated)

October 31, 2027

Last Updated

September 2, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will share

All anonymized data will be made available by the online publication date. These data will be placed in public servers for any interested researcher to access it.

Time Frame
Data will become permanently available by the online publication date.
Access Criteria
Any interested researcher will have access.

Locations